S&P Futures
3,985.00 +2.00 (+0.05%) Dow Futures
32,471.00 +15.00 (+0.05%) Nasdaq Futures
12,682.00 -6.50 (-0.05%) Russell 2000 Futures
1,765.80 +5.10 (+0.29%) Crude Oil
67.29 -0.35 (-0.52%) Gold
1,984.80 +2.00 (+0.10%)
Nocturne Acquisition Corporation (MBTC)
Chart Events
Performance Outlook
| Previous Close | 10.81 |
| Open | 10.80 |
| Bid | 4.76 x 1000 |
| Ask | 10.83 x 900 |
| Day's Range | 10.81 - 10.81 |
| 52 Week Range | 10.03 - 11.10 |
| Volume | |
| Avg. Volume | 1,047 |
| Market Cap | 57.5M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MBTC
Related Research
- Nocturne Acquisition CorporatioBLFS: Raising target price to $57.00BIOLIFE SOLUTIONS INC has an Investment Rating of HOLD; a target price of $57.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat2 years agoArgus Research
- PR Newswire
Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation
Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) ("Nocturne"), a publicly-traded special purpose acquisition company, today announced execution of a definitive business combination agreement with Cognos Therapeutics, Inc. ("Cognos"), a medical technology company focused on developing unique, radically advanced devices delivering drugs for the treatment of neurological diseases including brain and spinal cancers, neurodegenerative disorders (such as Alzheimer's and Parkinson's disease
- Simply Wall St.
Nocturne Acquisition Corporation (NASDAQ:MBTC) has caught the attention of institutional investors who hold a sizeable 36% stake
To get a sense of who is truly in control of Nocturne Acquisition Corporation ( NASDAQ:MBTC ), it is important to...
- ACCESSWIRE
Nocturne Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination
WILMINGTON, DE / ACCESSWIRE / July 5, 2022 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that an aggregate of $1,150,000 (the "Extension Payment") has been deposited into the Company's trust account for its public shareholders, representing $0.
